Discuss the total dose that will be taken in the country and in the laboratory
The final final will be delayed until February, when El Salvador will receive the first lot of vacancies against Covid-19, as part of the World Health Organization (OMS) donation.
Kate O’Brien, Director of Immunization of the OMS, announced that the donation of vacancies is part of the Global Access Fund Initiative for the Covid-19 Vacancies (Covax, by its English flags). The program turned over $ 7 million.
The Directorate of Immunization gives these Jews a virtual conversation with the media that “alone requires around 7,000 million dollars to bring enough vacancies to those countries (beneficiaries) up to fines of 2021. The initiative has earned 7,000 cones million dollars ”.
Although the total number of vacancies for sale in this first lot is known, El Salvador forms part of 92 beneficiary countries, due to its difficult economic situation. Honduras, Nicaragua and Dominicana are some of the favorite cities in the region.
VEA TAMBIÉN: Government should inform about risks and benefits of vacancies against COVID-19
“We will start our vacancies probably with fines of January and, if not, certainly with the principles of February and February, as far as the countries of Africa and South Asia and other countries of the world are 92 that have less capacity to pay for the vacancies that will be vacated and distributed at the same time as the high-altitude countries ”, the OMS staff demonstrated during a digital platform conversation.
The objective of the Covax mechanism of the OMS is to log vacancies for the 20% of the population in each participating country in the finals of this year. 92% of the poorest countries will be covered by their own guests.
As expressed by O’Brien, the vacancy that will be distributed is the BioNTech Pcifer, with the current El Salvador governing body has not officially expressed an agreement with the British-Swedish AstraZeneca. However, representatives of the Medical College expressed that the Bukele administration has advanced management with Pfizer BioNTech.
“We will review the data from the first that completed the revision, which is the Pfizer and the OMS issue that is known as a list of the most effective ways to use it, which means that it is confirmed that we revised it. dates and dates that are complementary to the standards, which are the higher standards that have been established for the global use of these vacancies, ”said O’Brien.
For now, in El Salvador, the only vacancy that the National Medicines Agency has for its import and distribution is AstraZeneca, which has been public since December 30th.
VEA TAMBIÉN: Authorize in El Salvador the use of the AstraZeneca vaccine against Covid-19
This donation from the OMS will serve so that El Salvador will receive millions of doses of the vaccine, but not enough that the governor has said that the plan is to vaccinate 4.5 million people.
As of December 2021, the Legislative Assembly approved Decree 389, a 50-million-dollar loan to the Inter-American Bank of Development, for the purchase of vacancies for COVID-19.
The Minister of Health, Francisco Alabí, has previously stated that the government will have 9 million doses, with a vacancy rate of 4.5 million people in the country. Priority in this series of vacancies for first-line staff (medical, nursing, soldiers, bombers, etc.), people arriving from 60 years and those with chronic illnesses (diabetes, hypertension, etc.) who are more vatbaar to contact COVID-19.
In fact, the country reports 48,255 cases of people infected with Covid-19. Of these, 1,398 were bankrupt and 42,902 were recovered, according to official information.